Rankings
▼
Calendar
BVS Q1 2022 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena
BVS
Bioventus Inc.
$593M
Q1 2022 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$117M
+43.4% YoY
Gross Profit
$76M
64.5% margin
Operating Income
-$21M
-18.3% margin
Net Income
-$11M
-9.6% margin
EPS (Diluted)
$-0.19
QoQ Revenue Growth
-10.1%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$25M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$675M
Stockholders' Equity
$450M
Cash & Equivalents
$27M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$117M
$82M
+43.4%
Gross Profit
$76M
$60M
+27.1%
Operating Income
-$21M
$22M
-197.5%
Net Income
-$11M
$25M
-145.2%
Revenue Segments
Pain Treatments
$52M
44%
Restorative Therapies
$34M
29%
Surgical Solutions
$31M
26%
Geographic Segments
UNITED STATES
$104M
89%
Non-US
$13M
11%
← FY 2022
All Quarters
Q2 2022 →